Foresite Capital Management Ii, LLC Insmed Inc Transaction History

Foresite Capital Management Ii, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$14.11 - $29.42 $3.34 Million - $6.96 Million	-236,547 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$13.63 - $33.98 $8.77 Million - $21.9 Million	-643,469 Reduced 73.12%	236,547 $3.79 Million
Q4 2019 Feb 05, 2020	SELL	$16.12 - $24.98 $564,200 - $874,300	-35,000 Reduced 3.83%	880,016 $21 Million
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $626,508 - $1.04 Million	-40,446 Reduced 4.23%	915,016 $16.1 Million
Q2 2019 Aug 13, 2019	BUY	$23.0 - $32.19 $828,598 - $1.16 Million	36,026 Added 3.92%	955,462 $24.5 Million
Q1 2019 May 14, 2019	SELL	$13.91 - $31.15 $670,462 - $1.5 Million	-48,200 Reduced 4.98%	919,436 $26.7 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $9.74 Million - $14.8 Million	448,991 Added 86.57%	967,636 $21.8 Million
Q4 2017 Feb 13, 2018	BUY	$26.43 - $31.78 $5.78 Million - $6.95 Million	218,645 Added 72.88%	518,645 $16.2 Million
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $3.48 Million - $9.36 Million	300,000	300,000 $9.36 Million

488

197M

892K

1.77M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.15B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Ii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Ii, LLC with notifications on news.